Tetrapropylammonium

Tetrapropylammonium

SCHEMBL5874252

CCC[N+](CCC)(CCC)CCC.[O-]c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 1/20 0.48
DNM1 Q05193 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 2/20 0.37
MAPK1 P28482 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CHRNB2 P17787 2/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA7 P36544 2/20 0.36
CHRNA4 P43681 2/20 0.36
HTT P42858 3/20 0.36
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
MLNR O43193 1/20 0.34
NR1I2 O75469 1/20 0.34
ESR1 P03372 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL887137 0.86 SLC22A1 (0.52) SLC22A1DNM1MEN1KMT2ATP53
Tetrapentylammonium SCHEMBL7931037 0.86 SLC22A1 (0.52) SLC22A1DNM1MEN1KMT2ATP53
Phenol SCHEMBL3860436 0.85 SLC22A1 (0.54) SLC22A1DNM1MEN1KMT2ATP53
Phenol SCHEMBL11789437 0.82 LMNA (0.35) SLC22A1CHRNB2CHRNB4CHRNA3CHRNA7
Tetrylammonium SCHEMBL2868658 0.80 CHRNA7 (0.43) MEN1KMT2ATP53SMN1; SMN2CHRNB2
Tetrapropylammonium SCHEMBL28223331 0.79 SLC22A1 (0.77) SLC22A1DNM1TP53SMN1; SMN2ALDH1A1
Tetrabuthylammonium SCHEMBL22089637 0.78 SLC22A1 (0.43) SLC22A1DNM1MEN1KMT2ATP53
Phenol SCHEMBL3852355 0.77 DNM1 (0.53) SLC22A1DNM1MEN1KMT2ATP53
Phenol SCHEMBL3849573 0.77 DNM1 (0.53) SLC22A1DNM1MEN1KMT2ATP53
Phenol SCHEMBL3857882 0.77 DNM1 (0.53) SLC22A1DNM1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111247156-B Aromatic aminosilicone functional material for capping porous dielectrics 默克专利股份有限公司 2023-10-27 CN disclosed
EP-3700912-B1 AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS MERCK PATENT GMBH (DE) 2022-09-14 EP disclosed
US-11031237-B2 Aromatic amino siloxane functionalized materials for use in capping porous dielectrics MERCK PATENT GMBH (DE) 2021-06-08 US disclosed
EP-3700912-A1 AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS Merck Patent GmbH (DE) 2020-09-02 EP disclosed
US-20200273701-A1 AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS EMD PERFORMANCE MATERIALS CORPORATION 2020-08-27 US disclosed
CN-111247156-A Aromatic aminosiloxane functional material for covering porous dielectrics 默克专利股份有限公司 2020-06-05 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031237-B2 Aromatic amino siloxane functionalized materials for use in capping porous dielectrics ZYX, YBX1, CDYL SLC22A1 3304/4885DNM1 3340/4885MEN1 4418/4885
US-20200273701-A1 AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS ZYX, YBX1, CDYL SLC22A1 3304/4885DNM1 3340/4885MEN1 4418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.